Impact of Standardized MONitoring for Detection of Atrial Fibrillation in Ischemic Stroke
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 3470 participants.
Also called NCT02204267
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose diagnostic
- Phase
- Not applicable
- Enrolled
- 3,470 participants
- Sponsor
- Registry
-
NCT02204267
-
- Other papers using this trial's data
- Excessive Supraventricular Ectopic Activity in Patients With Acute Ischemic Stroke Is Associated With Atrial Fibrillation Detection Within 24 Months After Stroke: A Predefined Analysis of the MonDAFIS Study
- Holter-ECG findings after acute ischemic stroke and TIA: A systematic analysis of the MonDAFIS randomized trial
- In-Hospital ECG Findings, Changes in Medical Management, and Cardiovascular Outcomes in Patients With Acute Stroke or Transient Ischemic Attack
- Systematic monitoring for detection of atrial fibrillation in patients with acute ischaemic stroke (MonDAFIS): a randomised, open-label, multicentre study
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Germany
- Registry status
- Completed
Technical summary
Registry record NCT02204267. Randomized; no masking; primary purpose diagnostic. Start 2014-12 (actual); primary completion 2020-05 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Impact of Standardized MONitoring for Detection of Atrial Fibrillation in Ischemic Stroke
- Acronym
- MonDAFIS
- Condition
- Stroke
- Condition
- Atrial Fibrillation
- Intervention (Other)
- prolonged ECG (electrocardiogram) monitoring
- Intervention (Device)
- ECG
- Lead sponsor
- Charite University, Berlin, Germany
- Collaborator
- Bayer Healthcare Pharmaceuticals, Inc./Bayer Schering Pharma
Record details
- Record id
cardio:ct-nct02204267- Content hash
6018547802590ffb9d75bf183d4de8f92dc31b7190d9a8da63db1a8a6486c462